224 related articles for article (PubMed ID: 29445832)
1. Analytical challenges in sports drug testing.
Thevis M; Krug O; Geyer H; Walpurgis K; Baume N; Thomas A
Anal Bioanal Chem; 2018 Mar; 410(9):2275-2281. PubMed ID: 29445832
[TBL] [Abstract][Full Text] [Related]
2. Challenges and perspectives in anti-doping testing.
Schamasch P; Rabin O
Bioanalysis; 2012 Jul; 4(13):1691-701. PubMed ID: 22831484
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry in sports drug testing-Analytical approaches and the athletes' exposome.
Thevis M; Görgens C; Guddat S; Thomas A; Geyer H
Scand J Med Sci Sports; 2024 Jan; 34(1):e14228. PubMed ID: 36539355
[TBL] [Abstract][Full Text] [Related]
4. Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.
Thevis M; Schänzer W
Rapid Commun Mass Spectrom; 2016 Mar; 30(5):635-51. PubMed ID: 26842585
[TBL] [Abstract][Full Text] [Related]
5. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
Vernec AR
Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
[TBL] [Abstract][Full Text] [Related]
6. Distinction of clenbuterol intake from drug or contaminated food of animal origin in a controlled administration trial - the potential of enantiomeric separation for doping control analysis.
Parr MK; Blokland MH; Liebetrau F; Schmidt AH; Meijer T; Stanic M; Kwiatkowska D; Waraksa E; Sterk SS
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2017 Apr; 34(4):525-535. PubMed ID: 27690842
[TBL] [Abstract][Full Text] [Related]
7. Detection of the diuretic hydrochlorothiazide in a doping control urine sample as the result of a non-steroidal anti-inflammatory drug (NSAID) tablet contamination.
Helmlin HJ; Mürner A; Steiner S; Kamber M; Weber C; Geyer H; Guddat S; Schänzer W; Thevis M
Forensic Sci Int; 2016 Oct; 267():166-172. PubMed ID: 27611956
[TBL] [Abstract][Full Text] [Related]
8. Annual banned-substance review - Analytical approaches in human sports drug testing.
Thevis M; Kuuranne T; Geyer H
Drug Test Anal; 2020 Jan; 12(1):7-26. PubMed ID: 31724288
[TBL] [Abstract][Full Text] [Related]
9. Determination of designer doping agent--2-ethylamino-1-phenylbutane--in dietary supplements and excretion study following single oral supplement dose.
Wójtowicz M; Jarek A; Chajewska K; Turek-Lepa E; Kwiatkowska D
J Pharm Biomed Anal; 2015 Nov; 115():523-33. PubMed ID: 26311473
[TBL] [Abstract][Full Text] [Related]
10. Annual banned-substance review: analytical approaches in human sports drug testing.
Thevis M; Kuuranne T; Geyer H; Schänzer W
Drug Test Anal; 2015 Jan; 7(1):1-20. PubMed ID: 25545248
[TBL] [Abstract][Full Text] [Related]
11. Analytical challenges in the detection of peptide hormones for anti-doping purposes.
Barroso O; Handelsman DJ; Strasburger C; Thevis M
Bioanalysis; 2012 Jul; 4(13):1577-90. PubMed ID: 22831474
[TBL] [Abstract][Full Text] [Related]
12. Sports drug testing: Analytical aspects of selected cases of suspected, purported, and proven urine manipulation.
Thevis M; Geyer H; Sigmund G; Schänzer W
J Pharm Biomed Anal; 2012 Jan; 57():26-32. PubMed ID: 21955645
[TBL] [Abstract][Full Text] [Related]
13. Annual banned-substance review: analytical approaches in human sports drug testing.
Thevis M; Kuuranne T; Walpurgis K; Geyer H; Schänzer W
Drug Test Anal; 2016 Jan; 8(1):7-29. PubMed ID: 26767774
[TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
[TBL] [Abstract][Full Text] [Related]
15. Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry.
Görgens C; Guddat S; Dib J; Geyer H; Schänzer W; Thevis M
Drug Test Anal; 2015; 7(11-12):973-9. PubMed ID: 25847280
[TBL] [Abstract][Full Text] [Related]
16. A synopsis of the adverse analytical and atypical findings between 2005 and 2011 from the Doping Control Laboratory of Athens in Greece.
Kioukia-Fougia N; Fragkaki A; Kiousi P; Leontiou IP; Dimopoulou H; Tsivou M; Lyris E; Georgakopoulos C
J Anal Toxicol; 2014; 38(1):16-23. PubMed ID: 24194481
[TBL] [Abstract][Full Text] [Related]
17. Annual banned-substance review: analytical approaches in human sports drug testing.
Thevis M; Kuuranne T; Geyer H; Schänzer W
Drug Test Anal; 2010 Apr; 2(4):149-61. PubMed ID: 20376830
[TBL] [Abstract][Full Text] [Related]
18. Sports drug testing using complementary matrices: Advantages and limitations.
Thevis M; Geyer H; Tretzel L; Schänzer W
J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951
[TBL] [Abstract][Full Text] [Related]
19. Annual banned-substance review: analytical approaches in human sports drug testing.
Thevis M; Kuuranne T; Geyer H; Schänzer W
Drug Test Anal; 2014; 6(1-2):164-84. PubMed ID: 24285613
[TBL] [Abstract][Full Text] [Related]
20. Running ahead of doping: analytical advances and challenges faced by modern laboratories ahead of Rio 2016.
Aquino Neto FR; Sarderla VF; Mirotti L; Pizzatti L
Bioanalysis; 2016 Sep; 8(17):1753-6. PubMed ID: 27491844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
